These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8241975)

  • 1. Merocyanine 540-sensitized photoinactivation of high-grade non-Hodgkin's lymphoma cells: potential application in autologous BMT.
    Itoh T; Messner HA; Jamal N; Tweeddale M; Sieber F
    Bone Marrow Transplant; 1993 Sep; 12(3):191-6. PubMed ID: 8241975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts.
    Yamazaki T; Sato Y; Sieber F
    Exp Hematol; 1997 Jul; 25(7):629-37. PubMed ID: 9216739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoradiation methods for purging autologous bone marrow grafts.
    Gulati S; Atzpodien J; Lemoli RM; Shimazaki C; Clarkson B
    Prog Clin Biol Res; 1990; 333():87-102. PubMed ID: 2137934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alkyl-lysophospholipid, ET-18-OCH3 synergistically enhances the Merocyanine 540-mediated photoinactivation of leukemia cells: implications for the extracorporeal purging of autologous hematopoietic stem cells.
    Yamazaki T; Sieber F
    Bone Marrow Transplant; 1997 Jan; 19(2):113-9. PubMed ID: 9116607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purging of small cell lung cancer cells from human bone marrow using ethiofos (WR-2721) and light-activated merocyanine 540 phototreatment.
    Meagher RC; Rothman SA; Paul P; Koberna P; Willmer C; Baucco PA
    Cancer Res; 1989 Jul; 49(13):3637-41. PubMed ID: 2543500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
    van Besien K; Margolin K; Champlin R; Forman S
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photochemical purging of autologous bone marrow grafts: assessment of damage to stem cells and the microenvironment in long-term marrow cultures.
    Kubo Y; Sieber F
    Bone Marrow Transplant; 1997 Jul; 20(1):27-31. PubMed ID: 9232252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma membrane properties regulating the sensitivity of leukemia, lymphoma, and solid tumor cells to merocyanine 540-sensitized photoirradiation.
    Smith OM; Gaffney DK; Anderson MS; McOlash L; Schober SL; Sieber F
    Exp Hematol; 1991 Sep; 19(8):785-8. PubMed ID: 1868893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
    Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of merocyanine 540-mediated photodynamic therapy by salicylate and related drugs.
    Traul DL; Anderson GS; Bilitz JM; Krieg M; Sieber F
    Photochem Photobiol; 1995 Oct; 62(4):790-9. PubMed ID: 7480156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.
    Kanteti R; Miller K; McCann J; Roitman D; Morelli J; Hurley C; Berkman E; Schenkein D
    Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of photodynamic therapy for elimination of residual leukemic cells in autologous transplants of hematopoietic progenitor cells].
    Hrkal Z; Grebenová D; Cajthamlová H; Soucek J; Bartosová J; Fuchs O; Marinov I; Kobylka P; Klamová H; Sponerová D
    Cas Lek Cesk; 2002 Sep; 141 Suppl():41-6. PubMed ID: 12428422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodamaging effects of merocyanine 540 on neutrophils and HL-60 cells.
    Smith OM; Traul DL; Sieber F
    Exp Hematol; 1992 Dec; 20(11):1278-84. PubMed ID: 1337324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
    Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
    Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selenoperoxidase-mediated cytoprotection against merocyanine 540-sensitized photoperoxidation and photokilling of leukemia cells.
    Lin F; Geiger PG; Girotti AW
    Cancer Res; 1992 Oct; 52(19):5282-90. PubMed ID: 1394132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro assessment of bone marrow endothelial colonies (CFU-En) in non-Hodgkin's lymphoma patients undergoing peripheral blood stem cell transplantation.
    Lanza F; Campioni D; Punturieri M; Moretti S; Dabusti M; Spanedda R; Castoldi G
    Bone Marrow Transplant; 2003 Dec; 32(12):1165-73. PubMed ID: 14647271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective elimination of malignant stem cells using photosensitizers followed by light treatment.
    Levy JG; Dowding C; Mitchell D; Sorrenti R; Yip S; Jamieson C
    Stem Cells; 1995 Jul; 13(4):336-43. PubMed ID: 7549891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of merocyanine 540-mediated photodynamic therapy on cellular immune functions: A role in the prophylaxis of graft-versus-host disease?
    Traul DL; Sieber F
    J Photochem Photobiol B; 2015 Dec; 153():153-63. PubMed ID: 26410039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient adenovirus-mediated gene expression in malignant human plasma cells: relative lymphoid cell resistance.
    Prince HM; Dessureault S; Gallinger S; Krajden M; Sutherland DR; Addison C; Zhang Y; Graham FL; Stewart AK
    Exp Hematol; 1998 Jan; 26(1):27-36. PubMed ID: 9430511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.